The effect of swim stress on morphine tolerance development and the possible role of nitric oxide in this process

Iranian Journal of Pharmaceutical Research

Volumn 4, Issue 3, 2005, Pages 167-173

  Davoodi, Farzaneh Ghiafeh ^a   Javan, Mohammad ^b   Ahmadiani, Abolhassan ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Analgesia; Morphine; Nitric oxide; Swim stress; Tolerance

Indexed keywords

EID: 34948831510     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Bilsky EJ, Inturrisi CE, Sadee W, Hruby VJ and Porreca F. Competitive and non- competitive NMDA antagonists block the development of antinociceptive tolerance to morphine,but not to selective mu and delta agonist in mice. Pain (1996) 68: 229-237
2. Twycross RG. Opioids. In: Wall PD and Melzacd R. (eds.) The Textbook of Pain. Churchill Livingston Ciyatel (1994) 943-962
3. Vaccarino AL and Couret LC Jr. Relationship between hypothalamic-pituitary-adrenal activity and blockade of tolerance to morphine analgesia by pain: Astrain comparison. Pain (1995) 63: 385-389
4. Rahman AFM, Takahashi M and Kaneto H. Role of GABA ergic systems in the development of morphine tolerance in formalin treated mice. Jpn. J. Pharmacol. (1995) 68: 207-211
5. Rahman AFM, Takahashi M and Kaneto H. Development of tolerance to morphine antinociception in mice treated with nociceptive stimulants. Jpn. J. Pharmacol. (1993) 63: 39-64
6. Vaccarino AL, Marek P, Kest B, Ben-Eliyahu S, Couret LC Jr., Kao B and Liebeskind JC. Morphine fails to produce tolerance when administered in the presence of formalin pain in rats. Brain Res. (1993) 627: 287-240
7. Pacak K, Palkovits M, Kvetnansky R, Yadid G, Kopin IJ and Goldstein DS. Effect of various stressors on in-vivo norepinephrine release in the hipothalamic paraventricular nucleus and on the pitritaryadrenalcortical axis. Ann. N. Y. Acad. Sci. (1995) 771: 115-130
8. Sternberg EM, Glowa JR, Smith MA, Calogero AE, Listwak SJ, Aksentijevich S, Chrousos GP, Wilder RL and Golp P. Corticotropin releasing hormone related behavioral and neuroendocrine responses to stress in Lewis and Fischer rats. Brain Res. (1992) 570: 54-60
9. Aloisi AM, Steenbergen HL, Van depoll NE and Farabollini F. Sex-dependent effects of restraint on nociception and pituitary-adrenal hormones in the rat. Physiol. Behav. (1994) 55: 789-793
10. Hendrie CA. ACTH: A single pretreatment enhances the analgesic efficiency of and prevent the development of tolerance to merphine. Physiol. Behav. (1988) 42: 41-45
11. Takahashi M, Sugimachi K and Kaneto H. Role of adrenal glucocorticoids in the blockade of analgesic tolerance to morphine by footshock stress exposure in mice. Jpn. J. Pharmacol. (1989) 51: 329-336
12. Wei E. Morphine analgesia, tolerance and physical dependence in the adrenalectomized rat. J. Pharmacol. (1973) 47: 693-699
13. Holaday JW, Dallman MF and Loh HH. Effect of ACTH and hypophesectomy on opiate tolerance and dependence. Life Sci. (1979) 24: 771-782
14. Vaccarino AL, Nores WL, Soignier RD and Olson RD. The role of corticosterone in the blockade of tolerance to morphine analgesia by formalin-induced pain in the rat. Neuroscience Letters (1997) 232: 139-142
15. Iyengar S, kim HS and Wood PL. Mu, k and ε opioid receptor modulation of the hypothalamic-pituitaryadrenocortical (HPA) axis: Subchronic tolerance studies of endogenous opioid peptides. Brain Res. (1987) 435: 220-226
16. Gonzalvez ML, Milanes MV and Vargas ML. Effect of acute and chronic administration of mu and K opioid agonists on the hypothalamic-pituitary-adrenocortical axis in the rat. Eur. J. Pharmacol. (1991) 200: 155-158
17. Martinez JA, Vargas ML, Fuente T, Del Rio J and Milanes MV. Plasma ß-endrophin and cortisol levels in morphine tolerant rats and in naloxone-induced withdrawal.Eur. J. Pharmacol. (1990)182: 117-123
18. Pechnick RN. Effect of opioids on the hypothalamuspituitary- adrenal axis. Ann. Rev. Pharmacol. Toxicol. (1993) 32: 353-382
19. Spinella M and Bodnar RJ. Nitric oxide synthase inhibition selectively potentiates swim stress antinociception in rat. Pharmacol. Biochem. Behav. (1994)272:47 -33
20. Adams ML, Kalicki JM, Meyer ER and Cicero TJ. Inhibition of the morphine withdrawal syndrome by a nitric oxide synthase inhibitor, NG-nitro-L-arginine methylester. Life Sci. (1993) 52: 245-249
21. Cappindijk SL, De Vries R and Dzoljic MR. Inhibitory effect of nitric oxide (NO) synthase inhibitors on naloxone-precipiated withdrawal syndrome in morphinedependent mice. Neurosci. Lett. (1993) 162: 97-100
22. Elliott K, Minami N, Kolesnikov YA, Pasternak GW and Inturrisi CE. The NMDA receptor antagonists, Ly 274614 and MK-801 and the nitric oxide syn thase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to Kappa opioids. Pain (1994) 56: 69-75
23. Majeed NH, Przewlocka B, Machelska H and Prezewlocki R. Inhibition of nitric oxide synthase attenuate the development of morphine tolerance and dependence in mice. Neuropharmacology (1994) 33: 189-162
24. Pataki I and Telegdy G. Further evidance that nitric oxide modifies acute and chronic morphine actions in mice. Eur. J. Pharmacol. (1998) 357: 157-62
25. Mayer DJ, Mao J, Holt J and Price DD. Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proc. Natl. Acad. Sci. (1999) 96: 7731-7736
26. Bugajski J, Gadek-Michalska A, Borycz J and Glod R. Social stress inhibits the nitric oxide effect on the corticotropin-releasing hormone-but not vasopressininduced pituitary-adrenocortical responsiveness. Brain Research (1999) 817: 220-225
27. Tsuchiya T, Kishimoto J and Nakayama Y. Marked increases in neuronal nitric oxide synthase (nNOS) mRNA and NADPH- diaphorase histostaining in adrenal cortex after immobilization stress in rats. Psychoneuroendocrinology (1996) 21: 287-293
28. Pasternak GW. Pharmacological mechanisms of opioid analgesic. Clin. Pharmacol. (1993) 16: 1-18
29. Mao J, Price DD and Mayer DY. Mechanisms of hyperalgesia and morphine tolerance. Pain (1995) 62: 259-274
30. Adams ML, Nock B, Truong R and Cicero TJ. Nitric oxide control of steroidogenesis: Endocrine effects of NG-nitro-l-arginine and comparisons to alcohol. Life Sci. (1992) 50: 35-40
31. Mogil JS, Stenberg WF, Balian H, Liebeskind JG and Sadowski B. Opioid and nonopioid swim stress induced analgesia: A parametric analysis in mice. Physiology & Behavior (1996) 59:123-132
32. Ahmadiani A, Hosseiny J, Semnanian S, Javan M, Saeedi F, Kamalinejad M and Saremi S. Antinociceptive and anti-inflammatory effects of Elaeagnus angustifolia fruit extract. J. Ethnopharmacol. (2000) 72: 287-292
33. Mirand KM, Espey MG and Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric oxide: Biology and chemistry (2001) 1:62-71
34. Guevara I, Iwanejko J, Dembinska A, Pankiewiez J, Wanat A, Anna P, Golabek I, Bartus S, Malezewska-Malec M and Szczudlik A. Determination of nitrite/nitrate in human biological material by the simple Griess reaction. Clinica Chimiea Acta (1998) 274: 177-188
35. Yamashiro O, Takahashi M and Kaneto H. Role of vasopressin in the blockade of the development of morphine tolerance by footshock and psychological stress. Arch. Int. Pharmacodyn. Ther. (1990) 307: 60-70.
36. Shanker G and Sharama RK. Beta-endrophine stimulates corticosterone synthesis in isolated rat adrenal cells. Biochem. Biophys. Res. Commun. (1979) 86: 1-5
37. Heybach JP and Vernikos J. Naloxone inhibit and morphine potentiates the adrenal steroidogenic response to ACTH. Eur. J. pharmacol. (1981) 75:1-6
38. Little PJ and Kuhn CM. Ontogentic studies of tolerance development: Effects of chronic morphine on the hypothalamic-pituitary–adrenal axis. Psychopharmacology (1995) 122: 78-84
39. Soares A, Leite R, Tatsuo M and Duarte I. Activation of ATP sensitive K channels: Mechanism of peripheral antinociceptive action of the nitric oxide donor, sodium nitroprusside. Eur. J. Pharmacol. (2000) 14: 1245-9
40. Lauretti GR Lima IC, Reis MP, Prado WA and Pereira NL. Oral ketamine and transdermal nitroglycerin as analgesic adjuvants to oral morphine therapy for cancer pain management. Anesthesiology (1999) 90: 1528-33
41. Wong CS, Hsu MM, Chou YY, Tao PL and Tung CS. Morphine tolerance increases [3 H] MK-801 binding affinity and constitutive neuronal nitric oxide synthase expression in rat spinal cord. Br. J. Anaesth. (2000) 85: 587-91
42. Kolesnikov YA, Pick CG and Pasternak GW. NGnitro-L-arginine prevents morphine tolerance. Eur. J. Pharmacol. (1992) 221: 399-400